These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12975661)

  • 1. [Health economics analysis of breast cancer screening].
    Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health economics analysis of colorectal screening].
    Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health economics analysis of cervical cancer screening].
    Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
    Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of monitoring the year 2002 of the Hungarian breast cancer screening program].
    Boncz I; Hoffer G; Sebestyén A; Dózsa C; Ember I
    Magy Onkol; 2005; 49(2):109-15. PubMed ID: 16249805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The attendance of the first screening round (2002-2003) of the Hungarian organized breast cancer screening program and its effect on the number of diagnostic and screening mammography].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Csaba D; Budai A; Ember I
    Orv Hetil; 2005 Sep; 146(38):1963-70. PubMed ID: 16238249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
    Szeto KL; Devlin NJ
    Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992.
    Leivo T; Sintonen H; Tuominen R; Hakama M; Pukkala E; Heinonen OP
    Cancer; 1999 Aug; 86(4):638-46. PubMed ID: 10440691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness.
    Rosenquist CJ; Lindfors KK
    Radiology; 1994 Jun; 191(3):647-50. PubMed ID: 8184041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening.
    Wang H; Kåresen R; Hervik A; Thoresen SO
    Cancer Causes Control; 2001 Jan; 12(1):39-45. PubMed ID: 11227924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
    Kattlove H; Liberati A; Keeler E; Brook RH
    JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
    Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
    Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic considerations in breast cancer screening of older women.
    Brown ML
    J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
    Elixhauser A
    Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening by mammography in Norway. Is it cost-effective?
    Norum J
    Ann Oncol; 1999 Feb; 10(2):197-203. PubMed ID: 10093689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.
    Ohnuki K; Kuriyama S; Shoji N; Nishino Y; Tsuji I; Ohuchi N
    Cancer Sci; 2006 Nov; 97(11):1242-7. PubMed ID: 16918992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening mammography and public health policy: the need for perspective.
    Wright CJ; Mueller CB
    Lancet; 1995 Jul; 346(8966):29-32. PubMed ID: 7603143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.